News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Repros Therapeutics Inc. (RPRX) Reports First Quarter 2014 Financial Results


5/12/2014 9:04:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas, May 12, 2014 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the first quarter ended March 31, 2014.

Financial Results

Net loss for the three month period ended March 31, 2014 was ($8.5) million, or ($0.37) per share, as compared to a net loss of ($7.4) million, or ($0.41) per share, for the same period in 2013. The increase in net loss was primarily due to increased payroll and benefits expenses, as a result of increased headcount, and increased legal expenses.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES